How has Krystal Biotech, Inc.'s allowance for doubtful accounts changed year-over-year?

Krystal Biotech, Inc.'s allowance for doubtful accounts increased by 55.6% year-over-year, from $52.28M to $81.34M.

What is the long-term trend for Krystal Biotech, Inc.'s allowance for doubtful accounts?

Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s allowance for doubtful accounts has grown at a 209.4% compound annual growth rate (CAGR), from $7.11M to $68.12M.

Krystal Biotech, Inc. KRYS Allowance for Doubtful Accounts

Allowance for Doubtful Accounts at other companies

ModernaMRNA

——

BiogenBIIB

——

Merck & Co.MRK

——

Other financials

Income statement

See full

Revenue$116.4M+31.9%

Operating income$53.7M+48.1%

Net income$55.9M+56.5%

EPS (diluted)$1.83+52.5%

Balance sheet

See full

Cash & equivalents$501.3M+62.4%

Total debt$9.1M-5.7%

Total equity$1.3B+29.7%

Total assets$1.4B+30.0%

Cash flow

See full

Operating cash flow$80.4M+160%

CapEx$7.1M+15.2%

Free cash flow$73.2M+196%

Valuation

See full

Market cap$10.26B+45.4%

Enterprise value$9.77B+44.2%

P/E45.6×-11.3×

P/S24.6×+3.4×

Profitability

See full

Operating margin42.8%+10.2pp

Net margin53.9%+16.7pp

FCF margin56.9%+16.5pp

Returns & leverage

See full

Return on equity19.9%+6.0pp

Debt / equity0×0.0×

Current ratio9.5×-0.2×

Where this comes from

Reported directly by Krystal Biotech, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.

The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Krystal Biotech, Inc.'s allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Krystal Biotech, Inc.'s allowance for doubtful accounts?: Krystal Biotech, Inc. (KRYS) reported allowance for doubtful accounts of $81.34M in Q1 2026.
How has Krystal Biotech, Inc.'s allowance for doubtful accounts changed year-over-year?: Krystal Biotech, Inc.'s allowance for doubtful accounts increased by 55.6% year-over-year, from $52.28M to $81.34M.
What is the long-term trend for Krystal Biotech, Inc.'s allowance for doubtful accounts?: Over 2 years (2023 to 2025), Krystal Biotech, Inc.'s allowance for doubtful accounts has grown at a 209.4% compound annual growth rate (CAGR), from $7.11M to $68.12M.